- Issuer ticker
-
BIO
- Reported as of
-
24 Oct 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
27 Oct 2026, 16:57:11 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Jonathan P. DiVincenzo
Filing notes and source
Key filing fact
Jonathan P. DiVincenzo filed Form 4 for BIO-RAD LABORATORIES, INC. (BIO) on 27 Oct 2026.
Key facts
- This page summarizes Jonathan P. DiVincenzo's Form 4 filing for BIO-RAD LABORATORIES, INC. (BIO).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 Oct 2026, 16:57.
Change
- Previous filing in this sequence was filed on 09 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001453524
Primary reporting owner
DiVincenzo Jonathan P.
- Relationship
-
President & COO
- Address
- C/O BIO-RAD LABORATORIES, INC., 1000 ALFRED NOBEL DRIVE, HERCULES
- Signature
- /s/ Jonathan P. DiVincenzo
- Signature date
- 25 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIO
transaction
Bio-Rad A Common Stock
Options Exercise
- Transaction value
- Shares
- +1,869
- Change %
- +95%
- Price
-
$0.000000*
- Shares after
- 3,832
- Date
- 24 Oct 2026
- Ownership
- Direct
- Footnotes
- F1
BIO
transaction
Bio-Rad A Common Stock
Tax liability
- Transaction value
- Shares
- -951
- Change %
- -25%
- Price
-
$369.95*
- Shares after
- 2,881
- Date
- 24 Oct 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -1,869
- Change %
- -33%
- Price
-
$0.000000*
- Shares after
- 3,740
- Date
- 24 Oct 2026
- Ownership
- Direct
- Underlying class
- Bio-Rad A Common Stock
- Underlying amount
- 1,869
- Exercise price
- $0.000000
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Explanation of responses
3 footnotes